Replies to post #21664 on Market Direction and Stock Trends

[DiscoverGold]

Is Biotech Poised for Upside Continuation?
By MPTrader | July 5, 2017

My near-term work in XBI (SPDR Biotech ETF) argues for one more upleg into new, high territory prior to a significant correction.

I have two constructive scenarios:

1) an upside thrust from above 77.00-76.80 micro support towards my next target of 82.00-83.00, or

2) a press into the area of the sharply-rising 2-0 DMA, now at 75.41, prior to the emergence of the anticipated upleg to 82-83.



https://www.mptrader.com/middayminute/

• DiscoverGold

Click on "In reply to", for Authors past commentaries